Cargando…
Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms’ Tumor Suppressor Wt1
Angiogenesis is one hallmark of cancer. Vascular endothelial growth factor (VEGF) is a known inducer of angiogenesis. Many patients benefit from antiangiogenic therapies, which however have limitations. Although VEGF is overexpressed in most tumors, different VEGF isoforms with distinct angiogenic p...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356959/ https://www.ncbi.nlm.nih.gov/pubmed/30641926 http://dx.doi.org/10.3390/cells8010041 |
_version_ | 1783391679707873280 |
---|---|
author | Wagner, Kay-Dietrich El Maï, Mounir Ladomery, Michael Belali, Tareg Leccia, Nathalie Michiels, Jean-François Wagner, Nicole |
author_facet | Wagner, Kay-Dietrich El Maï, Mounir Ladomery, Michael Belali, Tareg Leccia, Nathalie Michiels, Jean-François Wagner, Nicole |
author_sort | Wagner, Kay-Dietrich |
collection | PubMed |
description | Angiogenesis is one hallmark of cancer. Vascular endothelial growth factor (VEGF) is a known inducer of angiogenesis. Many patients benefit from antiangiogenic therapies, which however have limitations. Although VEGF is overexpressed in most tumors, different VEGF isoforms with distinct angiogenic properties are produced through alternative splicing. In podocytes, the Wilms’ tumor suppressor 1 (WT1) suppresses the Serine/arginine-rich protein-specific splicing factor kinase (SRPK1), and indirectly Serine/arginine-rich splicing factor 1 (Srsf1) activity, and alters VEGF splicing. We analyzed VEGF isoforms, Wt1, Srpk1, and Srsf1 in normal and tumor endothelium. Wt1, Srpk1, Srsf1, and the angiogenic VEGF164a isoform were highly expressed in tumor endothelium compared to normal lung endothelium. Nuclear expression of Srsf1 was detectable in the endothelium of various tumor types, but not in healthy tissues. Inducible conditional vessel-specific knockout of Wt1 reduced Wt1, Srpk1, and Srsf1 expression in endothelial cells and induced a shift towards the antiangiogenic VEGF120 isoform. Wt1(−KTS) directly binds and activates both the promoters of Srpk1 and Srsf1 in endothelial cells. In conclusion, Wt1 activates Srpk1 and Srsf1 and induces expression of angiogenic VEGF isoforms in tumor endothelium. |
format | Online Article Text |
id | pubmed-6356959 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-63569592019-02-06 Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms’ Tumor Suppressor Wt1 Wagner, Kay-Dietrich El Maï, Mounir Ladomery, Michael Belali, Tareg Leccia, Nathalie Michiels, Jean-François Wagner, Nicole Cells Article Angiogenesis is one hallmark of cancer. Vascular endothelial growth factor (VEGF) is a known inducer of angiogenesis. Many patients benefit from antiangiogenic therapies, which however have limitations. Although VEGF is overexpressed in most tumors, different VEGF isoforms with distinct angiogenic properties are produced through alternative splicing. In podocytes, the Wilms’ tumor suppressor 1 (WT1) suppresses the Serine/arginine-rich protein-specific splicing factor kinase (SRPK1), and indirectly Serine/arginine-rich splicing factor 1 (Srsf1) activity, and alters VEGF splicing. We analyzed VEGF isoforms, Wt1, Srpk1, and Srsf1 in normal and tumor endothelium. Wt1, Srpk1, Srsf1, and the angiogenic VEGF164a isoform were highly expressed in tumor endothelium compared to normal lung endothelium. Nuclear expression of Srsf1 was detectable in the endothelium of various tumor types, but not in healthy tissues. Inducible conditional vessel-specific knockout of Wt1 reduced Wt1, Srpk1, and Srsf1 expression in endothelial cells and induced a shift towards the antiangiogenic VEGF120 isoform. Wt1(−KTS) directly binds and activates both the promoters of Srpk1 and Srsf1 in endothelial cells. In conclusion, Wt1 activates Srpk1 and Srsf1 and induces expression of angiogenic VEGF isoforms in tumor endothelium. MDPI 2019-01-11 /pmc/articles/PMC6356959/ /pubmed/30641926 http://dx.doi.org/10.3390/cells8010041 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wagner, Kay-Dietrich El Maï, Mounir Ladomery, Michael Belali, Tareg Leccia, Nathalie Michiels, Jean-François Wagner, Nicole Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms’ Tumor Suppressor Wt1 |
title | Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms’ Tumor Suppressor Wt1 |
title_full | Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms’ Tumor Suppressor Wt1 |
title_fullStr | Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms’ Tumor Suppressor Wt1 |
title_full_unstemmed | Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms’ Tumor Suppressor Wt1 |
title_short | Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms’ Tumor Suppressor Wt1 |
title_sort | altered vegf splicing isoform balance in tumor endothelium involves activation of splicing factors srpk1 and srsf1 by the wilms’ tumor suppressor wt1 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356959/ https://www.ncbi.nlm.nih.gov/pubmed/30641926 http://dx.doi.org/10.3390/cells8010041 |
work_keys_str_mv | AT wagnerkaydietrich alteredvegfsplicingisoformbalanceintumorendotheliuminvolvesactivationofsplicingfactorssrpk1andsrsf1bythewilmstumorsuppressorwt1 AT elmaimounir alteredvegfsplicingisoformbalanceintumorendotheliuminvolvesactivationofsplicingfactorssrpk1andsrsf1bythewilmstumorsuppressorwt1 AT ladomerymichael alteredvegfsplicingisoformbalanceintumorendotheliuminvolvesactivationofsplicingfactorssrpk1andsrsf1bythewilmstumorsuppressorwt1 AT belalitareg alteredvegfsplicingisoformbalanceintumorendotheliuminvolvesactivationofsplicingfactorssrpk1andsrsf1bythewilmstumorsuppressorwt1 AT leccianathalie alteredvegfsplicingisoformbalanceintumorendotheliuminvolvesactivationofsplicingfactorssrpk1andsrsf1bythewilmstumorsuppressorwt1 AT michielsjeanfrancois alteredvegfsplicingisoformbalanceintumorendotheliuminvolvesactivationofsplicingfactorssrpk1andsrsf1bythewilmstumorsuppressorwt1 AT wagnernicole alteredvegfsplicingisoformbalanceintumorendotheliuminvolvesactivationofsplicingfactorssrpk1andsrsf1bythewilmstumorsuppressorwt1 |